WON TECH (336570) Fundamentals 2026 — P/E 13.2x, Revenue Analysis | SniperIQ
WON TECH (336570) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩443.3B, trading at ₩4990.00 on the KOE. This SniperIQ fundamentals page covers WON TECH's valuation (P/E 13.2x, P/B 2.7x), profitability (net margin 21.1%), revenue (₩156.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is WON TECH's market cap?
WON TECH (336570) has a market capitalization of approximately ₩443.3B, trading at ₩4990.00 on the KOE. Market cap moves with the live share price.
What is WON TECH's P/E ratio?
WON TECH's trailing twelve-month P/E ratio is 13.2x, with a price-to-book (P/B) of 2.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is WON TECH?
WON TECH runs a net profit margin of 21.1%, a gross margin of 71.8%, and an operating margin of 30.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does WON TECH generate?
WON TECH reported revenue of ₩156.8B for fiscal year 2025, with net income of ₩35.2B and earnings per share (EPS) of 392.8. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does WON TECH pay a dividend?
WON TECH offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is WON TECH financially healthy?
WON TECH carries a debt-to-equity ratio of 0.13x and a current ratio of 3.05x, with a market beta of 0.84. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is WON TECH a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For WON TECH (336570) the key facts are: market cap ₩443.3B, P/E 13.2x, revenue ₩156.8B, 52-week range 4945-13380. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track WON TECH's full fundamentals live
Get WON TECH's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.